TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
Clinical trial NCT03920254 · TERMINATED
Trial details
- NCT number
- NCT03920254
- Sponsor
- Theravance Biopharma
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2021-10-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.